| Year |
Citation |
Score |
| 2017 |
Frederick DR, Goggins JA, Sabbagh LM, Freytag LC, Clements JD, McLachlan JB. Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4 T cells following parenteral immunization. Mucosal Immunology. 11: 549-561. PMID 28792004 DOI: 10.1038/Mi.2017.70 |
0.562 |
|
| 2016 |
Clements JD, Freytag LC. Parenteral Vaccination Can Be An Effective Means of Inducing Protective Mucosal Responses. Clinical and Vaccine Immunology : Cvi. PMID 27122485 DOI: 10.1128/Cvi.00214-16 |
0.542 |
|
| 2014 |
Li T, Steede NK, Nguyen HN, Freytag LC, McLachlan JB, Mettu RR, Robinson JE, Landry SJ. Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein. Journal of Virology. 88: 9605-15. PMID 24920818 DOI: 10.1128/Jvi.00789-14 |
0.347 |
|
| 2013 |
Steede NK, Rust BJ, Hossain MM, Freytag LC, Robinson JE, Landry SJ. Shaping T cell - B cell collaboration in the response to human immunodeficiency virus type 1 envelope glycoprotein gp120 by peptide priming. Plos One. 8: e65748. PMID 23776539 DOI: 10.1371/Journal.Pone.0065748 |
0.437 |
|
| 2012 |
Tomchuck SL, Norton EB, Garry RF, Bunnell BA, Morris CA, Freytag LC, Clements JD. Mesenchymal stem cells as a novel vaccine platform. Frontiers in Cellular and Infection Microbiology. 2: 140. PMID 23162801 DOI: 10.3389/Fcimb.2012.00140 |
0.533 |
|
| 2012 |
Norton EB, Lawson LB, Mahdi Z, Freytag LC, Clements JD. The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigens. Infection and Immunity. 80: 2426-35. PMID 22526674 DOI: 10.1128/Iai.00181-12 |
0.531 |
|
| 2012 |
Lawson LB, Clements JD, Freytag LC. Mucosal immune responses induced by transcutaneous vaccines. Current Topics in Microbiology and Immunology. 354: 19-37. PMID 22435116 DOI: 10.1007/82_2010_113 |
0.574 |
|
| 2011 |
Norton EB, Lawson LB, Freytag LC, Clements JD. Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant. Clinical and Vaccine Immunology : Cvi. 18: 546-51. PMID 21288994 DOI: 10.1128/Cvi.00538-10 |
0.464 |
|
| 2007 |
Lawson LB, Freytag LC, Clements JD. Use of nanocarriers for transdermal vaccine delivery. Clinical Pharmacology and Therapeutics. 82: 641-3. PMID 17998911 DOI: 10.1038/Sj.Clpt.6100425 |
0.447 |
|
| 2007 |
Uddowla S, Freytag LC, Clements JD. Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens. Vaccine. 25: 7984-93. PMID 17933440 DOI: 10.1016/J.Vaccine.2007.09.030 |
0.604 |
|
| 2007 |
DuBois AB, Freytag LC, Clements JD. Evaluation of combinatorial vaccines against anthrax and plague in a murine model. Vaccine. 25: 4747-54. PMID 17482725 DOI: 10.1016/J.Vaccine.2007.03.048 |
0.624 |
|
| 2005 |
Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infection and Immunity. 73: 5256-61. PMID 16041052 DOI: 10.1128/Iai.73.8.5256-5261.2005 |
0.517 |
|
| 2005 |
Glynn A, Freytag LC, Clements JD. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine. 23: 1957-65. PMID 15734068 DOI: 10.1016/J.Vaccine.2004.10.025 |
0.577 |
|
| Show low-probability matches. |